The Biotech Growth Trust PLC

LSE:BIOG Stock Report

Market Cap: UK£336.2m

Biotech Growth Trust Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure22yrs

Recent management updates

Recent updates


CEO

Biotech Growth Trust has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Andrew Joy
Senior Independent Director12.2yrsUK£24.00kno data
Sven Borho
Non Executive Director18.2yrsUK£24.00kno data
Peter Keen
Director26.9yrsUK£26.00kno data
Paul Gaunt
Director26.9yrsUK£24.00kno data
Roger Yates
Directorno datano data0.045%
£ 150.9k
William Waldegrave
Chairman25.9yrsUK£34.00kno data
J. Anthony V. Townsend
Director of Finsbury Growthno dataUK£11.00kno data
Dame Davies
Independent Non-Executive Director12.2yrsUK£24.00kno data

22.0yrs

Average Tenure

69yo

Average Age

Experienced Board: BIOG's board of directors are seasoned and experienced ( 22 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.